U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Heterocyclic thrombin inhibitors

Patent 5583146 Issued on December 10, 1996. Estimated Expiration Date: Icon_subject January 17, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

଱ hydroxy tripeptide substrates
Patent #: 4244865
Issued on: 01/13/1981
Inventor: Ali ,   et al.

N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
Patent #: 4258192
Issued on: 03/24/1981
Inventor: Okamoto ,   et al.

Novel peptidyl-arginine aldehyde derivatives and process for the preparation thereof
Patent #: 4316889
Issued on: 02/23/1982
Inventor: Bajusz ,   et al.

Novel anticoagulant agmatine derivatives and process for the preparation thereof
Patent #: 4346078
Issued on: 08/24/1982
Inventor: Bajusz ,   et al.

Phenol derivatives
Patent #: 4904661
Issued on: 02/27/1990
Inventor: Pilgrim, et al.

S-nitrosocaptopril compounds and the use thereof
Patent #: 5002964
Issued on: 03/26/1991
Inventor: Loscalzo

Tripeptide derivatives and protease inhibitor composition comprising the same
Patent #: 5153176
Issued on: 10/06/1992
Inventor: Abe, et al.

Peptide aldehydes as antithrombotic agents Patent #: 5380713
Issued on: 01/10/1995
Inventor: Balasubramanian, et al.

Inventors

Assignee

Application

No. 373334 filed on 01/17/1995

US Classes:

514/326, The additional ring is a hetero ring514/19, 2 peptide repeating units in known peptide chain514/183, Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI514/200, 1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.)514/210.18, Additional hetero ring attached directly or indirectly to the four-membered hetero ring by nonionic bonding514/217.04, The additional hetero ring is six-membered and contains nitrogen514/217.06, The additional hetero ring is a 1,3 diazine (including hydrogenated)514/217.07, Polycyclo ring system having the additional six-membered hetero ring as one of the cyclos514/217.08, The additional hetero ring is five-membered and contains nitrogen514/231.5, Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding514/233.8, Plural ring hetero atoms in the bicyclo ring system514/234.5, Plural ring nitrogens in the bicyclo ring system514/235.2, Ring nitrogen in the bicyclo ring system514/235.5, Ring nitrogen in the additional hetero ring514/235.8, Plural ring nitrogens in the additional hetero ring (e.g., imidazole, pyrazine, etc.)514/236.8, Ring chalcogen in the additional hetero ring (e.g., oxazole, etc.)514/237.2, The additional hetero ring is attached indirectly to the morpholine ring by an acyclic chain having a hetero atom as a chain member514/252.03, The additional hetero ring is six-membered consisting of one nitrogen and five carbon atoms514/252.05, The additional hetero ring is a five-membered nitrogen hetero ring514/255.05, Additional hetero ring attached directly or indirectly to the 1,4-diazine ring by nonionic bonding514/256, 1,3-diazines (e.g., pyrimidines, etc.)514/263.22, The additional hetero ring is six-membered consisting of one nitrogen and five carbons514/303, Exactly three ring nitrogens in the bicyclo ring system514/314, Additional hetero ring attached directly or indirectly to the quinoline ring system by nonionic bonding514/316, Plural piperidine rings514/318, The additional ring is a six-membered hetero ring consisting of one nitrogen and five carbon atoms514/319, The additional ring is one of the cyclos in a polycyclo ring system514/321, Plural hetero atoms in the polycyclo ring system540/200, Hetero ring is four-membered containing nitrogen and having chalcogen double bonded directly to a ring carbon which is adjacent to the ring nitrogen540/354, Additional chalcogen bonded directly to the hetero ring540/480, Additional hetero ring attached directly or indirectly to the hetero ring by nonionic bonding540/483, Plural nitrogens attached indirectly to the hetero ring by acyclic nonionic bonding540/544, The hetero ring contains chalcogen540/553, The hetero ring contains plural nitrogens (e.g., 1,3-diazepines, etc.)540/597, The additional hetero ring is six-membered and contains nitrogen540/600, The additional hetero ring is 1,3-diazine (including hydrogenated)540/603, Plural hetero atoms in the additional hetero ring544/124, Six-membered ring consisting of one nitrogen and five carbons (e.g., pyridine, etc.)544/127, The additional six-membered hetero ring is one of the cyclos in a bicyclo ring system544/128, Quinoline or isoquinoline (including hydrogenated)544/129, Piperidine ring544/130, Double bonded divalent chalcogen containing544/133, The five-membered hetero ring has at least sulfur and nitrogen as ring hetero atoms544/135, Benzothiazoles (including hydrogenated)544/137, The five-membered hetero ring has at least oxygen and nitrogen as ring hetero atoms544/139, 1,3-Diazole ring (including hydrogenated)544/141, Five-membered hetero ring consisting of one nitrogen and four carbons544/238, 1,2-diazines which contain an additional hetero ring544/242, 1,3-diazines544/277, Nitrogen attached directly or indirectly to the purine ring system by nonionic bonding544/283, The other cyclo in the bicyclo ring system is a benzene ring (e.g., quinazoline, etc.)544/336, 1,4-diazines546/118, Three ring nitrogens in the bicyclo ring system546/152, Quinolines (including hydrogenated)546/190, Having -C(=X)-, wherein X is chalcogen, attached indirectly to a piperdine ring by nonionic bonding546/193, Pyridine ring or partially hydrogenated pyridine ring546/198, Ring nitrogen in the polycyclo ring system546/208, Ring nitrogen in the additional hetero ring546/209, Ring sulfur or ring oxygen in the additional hetero ring546/210, Plural ring nitrogens in the additional hetero ring546/211, 1,2-diazole (including hydrogenated)546/212, The additional hetero ring consists of one sulfur and four carbons546/214The additional hetero ring consists of one oxygen and four carbons

Examiners

Primary: Chang, Ceila

Attorney, Agent or Firm

Foreign Patent References

  • 479489 EP. 04/13/1992
  • 526877 EP. 02/13/1993
  • 0669317A1 EP. 03/13/1995
  • WO9311152 WO. 06/13/1993
  • WO9429336 WO. 12/13/1994

International Classes

A61K 031/445
A61K 031/40
C07D 401/12
C07D 207/09
C07D 211/
28.09

Abstract

Heterocyclic thrombin inhibitors are provided which have the structure ##STR1## wherein n, R, R1, R2, R3, G, Gx, R6', Ra, Xa, R6, Rb, R3, p, Q, A and R4 are as defined herein.

Other References

  • Zablocki et al. "Potent in vitro and in vivo inhibitor of platelet aggregation based on the Arg-Gly-Asp-Phe sequence of fibrinogen . . . " J. Med. Chem. v36 pp. 1811-1819 (1993)
  • Robert M. Knabb et al, "In Vivo Characterization of a New Synthetic Thrombin Inhibitor," Thrombosis and Hemostasis (1992) 67, 56-59
  • Charles V. Jackson et al, "Pharmacological Assessment of the Antithrombotic Activity of the Peptide Thrombin Inhibitor, D-Methyl-Phenylalanyl-Prolyl-Arginal (GYKI-14766), in a Canine Model of Coronary Artery Thrombosis," J. Pharm. Exp. Ther. (1992) 261, 546-552
  • Greissbach, U. et al "Peptide aldehydes as inhibitors of proteolytic enzymes-synthetic aspects" CA102:181323a (1983)
  • Shuman, R. T. et al "Highly Selective Tripeptide Thrombin Inhibitors" J. Med. Chem. 36, 314-19 (1993)
  • Bajusz, S. et al "Highly Active and Selective Anticoagulants" J. Med. Chem. 33, 1729-35 (1990)
  • Rubini, E. et al "Synthesis of Isosteric Methylene-oxy Pseudodipeptide Analogues as Novel Amide Bond Surrogate Units" Tetrahedron 42, 6039-45 (1986)
  • Spatola, A. F. et al "Amide Bond Surrogates: Pseudopeptides and Macrocycles" Tetrahedron 44, 821-833 (1988)
  • McOmie, J. F. W. "Protective Groups in Organic Chemistry" Plenum Press, pp. 46, 55-57, 73 (1973)
  • Banner, D. et al "Serine Proteases: 3D Structures, Mechanisms of Action and Inhibitors" Prospect. Med. Chem. Bernard (Ed), Verlag Publishing, pp. 27-43 (1993)
  • Hackh's Chemical Dictionary, McGraw-Hill, p. 16 (1982)
  • Burger, A. "A Guide to the Chemical Basis of Drug Design" Wiley, Science, p. 15 (1984
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
 
Sign InRegister
Username  
Password   
forgot password?